+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)

Global Industry Insight: Human Insulin Market Development and Demand Forecast to 2020

  • ID: 3359689
  • Report
  • Region: Global
  • 125 pages
  • Prescient & Strategic Intelligence Private Limited
1 of 5

FEATURED COMPANIES

  • ADOCIA
  • Biocon Ltd.
  • Eli Lilly and Company
  • GlaxoSmithKline Plc
  • Julphar
  • Merck & Co.
  • MORE
Human insulin in the report refers to synthetic insulin manufactured in laboratories by growing insulin protein with the help of E. coli bacteria

Key findings of Human Insulin Market:

The key findings of the report “Global Industry Insight: Human Insulin Market Development and Demand Forecast to 2020” include:
  • Increasing prevalence of diabetic population, rising prevalence of obesity, and rise in geriatric population are major factors driving the growth of the human insulin market
  • Strict regulatory requirements for approval of insulin and high cost of insulin analog inhibits the growth of the human insulin market
  • Geographically, North America has the largest share in global human insulin market, while Asia-Pacific has emerged as the fastest growing region
  • Based on the type, modern human insulin has the largest market share in the human insulin market
  • Increasing usage of insulin pens for the administration of insulin helps to inject insulin accurately. In addition, growing demand of biosimilar drugs due to its cost effectiveness is an opportunity for the growth of the market.
Human insulin market is growing moderately due to increase in prevalence of diabetic population, rise in geriatric population, rising awareness of diabetes and rising prevalence of obesity. However, strict regulatory requirements for approval of insulin and high cost of analog are inhibiting the growth of the global human insulin market.

Globally, modern human insulin has the largest market share and is also the fastest growing human insulin type. In addition, long acting human insulin has the largest market share in the modern human insulin market, and premixed human insulin is the fastest growing modern human insulin in the market. Long acting human insulin is prescribed by physicians for the treatment of type 2 diabetes. It is absorbed slowly and works for long time to control the sugar level between meal and sleep.

The key competitors in the human insulin market include Sanofi, Novo Nordisk A/S, Eli Lilly and Company, GlaxoSmithKline Plc, Pfizer, Inc., Merck & Co., and Julphar.

Report Coverage
  • Provides comprehensive understanding of the market with the help of informed market outlook, opportunities, challenges, trends, size and growth, competitive analysis, major competitors and Porter analysis
  • Identifies the key drivers of growth and challenges of the key industry players. Also, assesses the future impact of the propellants and restraints on the market
  • Uncovers potential demands in the market
  • Porter analysis identifies competitive forces within the market
  • Provides information on the historical and current market size and the future potential of the market
  • Provides sizes of key regional markets using yardsticks of processes, segments, products, end user and technology, etc (as applicable)
  • Highlights the competitive scenario of the market, major competitors, market share, benchmarking, investments and merger acquisitions
  • Provides profiles of major competitors of the market including details of their operations, product and services, recent developments and key financial metrics. Profiles provide better understanding of competition as well as the demands of the market.
READ MORE
Note: Product cover images may vary from those shown
2 of 5

FEATURED COMPANIES

  • ADOCIA
  • Biocon Ltd.
  • Eli Lilly and Company
  • GlaxoSmithKline Plc
  • Julphar
  • Merck & Co.
  • MORE
1 Research Scope And Methodology
1.1 Market Definition
1.2 Market Scope
1.2.1 Market Breakdown By Type
1.2.2 Market Breakdown By Brand
1.2.3 Market Breakdown By Geography
1.3 Research Methodology And Sources

2 Executive Summary
2.1 Key Findings
2.2 Research Summary

3 Market Outlook
3.1 Introduction
3.2 Trends In The Market
3.2.1 Rising Usage Of Insulin Pen For The Administration Of Human Insulin
3.3 Opportunities In The Market
3.3.1 Growing Demand Of Biosimilar Drugs Due To Its Cost Effectiveness
3.4 Factors Driving The Market And Its Impact On Market Forecast
3.4.1 Rising Aging Population
3.4.2 Increasing Diabetic Population
3.4.3 Rising Prevalence Of Obesity
3.4.4 Technological Advancement In Drug Delivery Devices
3.4.5 Increasing Awareness About Diabetic Care
3.4.6 Impact Analysis Of Drivers On Market Forecast
3.5 Factors Hindering The Market And Its Impact On Market Forecast
3.5.1 High Insulin Analogue Cost
3.5.2 Strict Regulatory Requirements For Approval Of Human Insulin
3.5.3 Impact Analysis Of Restraints On Market Forecast

4 Global Market Size And Forecasts (2011-2020)
4.1 Global Market Breakdown By Type
4.2 Global Tradition Human Insulin Market Breakdown By Type
4.3 Global Modern Human Insulin Market Breakdown By Type
4.4 Global Market Breakdown By Region

5 Global Market Breakdown By Type
5.1 Traditional Human Insulin Market Breakdown By Region
5.2 Modern Human Insulin Market Breakdown By Region

6 Global Traditional Human Insulin Market Breakdown By Type
6.1 Short Acting Human Insulin Market Breakdown By Region
6.2 Intermediate Acting Human Insulin Market Breakdown By Region
6.3 Premixed Human Insulin Market Breakdown By Region

7 Global Modern Human Insulin Market Breakdown By Type
7.1 Long Acting Human Insulin Market Breakdown By Region
7.2 Rapid Acting Human Insulin Market Breakdown By Region
7.3 Premixed Human Insulin Market Breakdown By Region

8 Global Market Breakdown By Brand

9 Global Market Breakdown By Region
9.1 North America Market Breakdown By Country, Technology, End Users And Application
9.1.1 The U.S. Market Breakdown By Type Of Human Insulin, By Type Of Traditional Human Insulin, And By Type Of Modern Human Insulin
9.1.2 Canada Market Breakdown By Type Of Human Insulin, By Type Of Traditional Human Insulin, And By Type Of Modern Human Insulin
9.2 Europe Market Breakdown By Country, Technology, End Users And Application
9.2.1 Germany Market Breakdown By Type Of Human Insulin, By Type Of Traditional Human Insulin, And By Type Of Modern Human Insulin
9.2.2 The U.K. Market Breakdown By Type Of Human Insulin, By Type Of Traditional Human Insulin, And By Type Of Modern Human Insulin
9.2.3 France Market Breakdown By Type Of Human Insulin, By Type Of Traditional Human Insulin, And By Type Of Modern Human Insulin
9.3 Asia-Pacific Market Breakdown By Country, Technology, End Users And Application
9.3.1 Japan Market Breakdown By Type Of Human Insulin, By Type Of Traditional Human Insulin, And By Type Of Modern Human Insulin
9.3.2 China Market Breakdown By Type Of Human Insulin, By Type Of Traditional Human Insulin, And By Type Of Modern Human Insulin
9.3.3 India Market Breakdown By Type Of Human Insulin, By Type Of Traditional Human Insulin, And By Type Of Modern Human Insulin
9.4 Rest Of The World (Row) Market Breakdown By Type, By Type Of Traditional Human Insulin And By Type Of Modern Human Insulin

10 Competitive Analysis And Market Share
10.1 Porter's Five Forces Of Competitive Position Analysis
10.1.1 Bargaining Power Of Buyers
10.1.2 Bargaining Power Of Suppliers
10.1.3 Threat Of New Entrants
10.1.4 Intensity Of Rivalry
10.1.5 Threat Of Substitutes
10.2 Competitive Positioning Of Key Competitors

11 Company Profiles
11.1 Biocon Ltd.
11.1.1 Business Overview
11.1.2 Products And Services
11.1.3 Recent Developments
11.1.4 Key P&L Metrics
11.2 Tonghuadongbao Pharmaceuticals Co., Ltd
11.2.1 Business Overview
11.2.2 Products And Services
11.2.3 Recent Developments
11.2.4 Key P&L Metrics
11.3 Adocia
11.3.1 Business Overview
11.3.2 Products And Services
11.3.3 Recent Developments
11.3.4 Key P&L Metrics
11.4 Merck & Co.
11.4.1 Business Overview
11.4.2 Products And Services
11.4.3 Recent Developments
11.4.4 Key P&L Metrics
11.5 Julphar
11.5.1 Business Overview
11.5.2 Products And Services
11.5.3 Recent Developments
11.5.4 Key P&L Metrics
11.6 Pfizer, Inc.
11.6.1 Business Overview
11.6.2 Products And Services
11.6.3 Recent Developments
11.6.4 Key P&L Metrics
11.7 Bristol-Myers Squibb Company
11.7.1 Business Overview
11.7.2 Products And Services
11.7.3 Recent Developments
11.7.4 Key P&L Metrics
11.8 Glaxosmithkline Plc
11.8.1 Business Overview
11.8.2 Products And Services
11.8.3 Recent Developments
11.8.4 Key P&L Metrics
11.9 Oramed Pharmaceuticals, Inc.
11.9.1 Business Overview
11.9.2 Products And Services
11.9.3 Recent Developments
11.9.4 Key P&L Metrics
11.10 Novo Nordisk A/S
11.10.1 Business Overview
11.10.2 Products And Services
11.10.3 Recent Developments
11.10.4 Key P&L Metrics
11.11 Eli Lilly And Company
11.11.1 Business Overview
11.11.2 Products And Services
11.11.3 Recent Developments
11.11.4 Key P&L Metrics
11.12 Sanofi
11.12.1 Business Overview
11.12.2 Products And Services
11.12.3 Recent Developments
11.12.4 Key P&L Metrics

12 Appendix
12.1 List Of Abbreviations

List Of Figures
Fig. 1 Market Scope For Global Human Insulin Market
Fig. 2 Research Methodology For Global Human Insulin Market
Fig. 3 Production Of Human Insulin
Fig. 4 Aging Population In Major Regions, In % (2000-2050)
Fig. 5 Number Of People Suffering From Diabetes Aged 20-79 Years, 2013 And 2035
Fig. 6 Prevalence Of Overweight Men Aged 30 And Above, In % (2005 And 2015)
Fig. 7 Prevalence Of Overweight Women Aged 30 And Above, In % (2005 And 2015)
Fig. 8 Global Human Insulin Market Share By Type (2014)
Fig. 9 Global Traditional Human Insulin Market Share By Type (2014)
Fig. 10 Global Modern Human Insulin Market Share By Type (2014)
Fig. 11 Global Human Insulin Market Share By Region (2014)
Fig. 12 Global Traditional Human Insulin Market Share By Region (2014)
Fig. 13 Global Modern Human Insulin Market Share By Region (2014)
Fig. 14 Global Short Acting Human Insulin Market Share By Region (2014)
Fig. 15 Global Intermediate Acting Human Insulin Market Share By Region (2014)
Fig. 16 Global Premixed Human Insulin Market Share By Region (2014)
Fig. 17 Global Long Acting Human Insulin Market Share By Region (2014)
Fig. 18 Global Rapid Acting Human Insulin Market Share By Region (2014)
Fig. 19 Global Premixed Human Insulin Market Share By Region (2014)
Fig. 20 Global Human Insulin Market Share By Brand (2014)
Fig. 21 North American Human Insulin Market Share By Country (2014)
Fig. 22 North America Human Insulin Market Share By Type (2014)
Fig. 23 North America Traditional Human Insulin Market Share By Type (2014)
Fig. 24 North America Modern Human Insulin Market Share By Type (2014)
Fig. 25 The U.S. Human Insulin Market Share By Type (2014)
Fig. 26 The U.S. Traditional Human Insulin Market Share By Type (2014)
Fig. 27 The U.S. Modern Human Insulin Market Share By Type (2014)
Fig. 28 Canada Human Insulin Market Share By Type (2014)
Fig. 29 Canada Traditional Human Insulin Market Share By Type (2014)
Fig. 30 Canada Modern Human Insulin Market Share By Type (2014)
Fig. 31 Europe Human Insulin Market Share By Country (2014)
Fig. 32 Europe Human Insulin Market Share By Type (2014)
Fig. 33 Europe Traditional Human Insulin Market Share By Type (2014)
Fig. 34 Europe Modern Human Insulin Market Share By Type (2014)
Fig. 35 Germany Human Insulin Market Share By Type (2014)
Fig. 36 Germany Traditional Human Insulin Market Share By Type (2014)
Fig. 37 Germany Modern Human Insulin Market Share By Type (2014)
Fig. 38 The U.K. Human Insulin Market Share By Type (2014)
Fig. 39 The U.K. Traditional Human Insulin Market Share By Type (2014)
Fig. 40 The U.K. Modern Human Insulin Market Share By Type (2014)
Fig. 41 France Human Insulin Market Share By Type (2014
Fig. 42 France Traditional Human Insulin Market Share By Type (2014)
Fig. 43 France Modern Human Insulin Market Share By Type (2014)
Fig. 44 Asia-Pacific Human Insulin Market Share By Country (2014)
Fig. 45 Asia-Pacific Human Insulin Market Share By Type (2014)
Fig. 46 Asia-Pacific Traditional Human Insulin Market Share By Type (2014)
Fig. 47 Asia-Pacific Modern Human Insulin Market Share By Type (2014)
Fig. 48 Japan Human Insulin Market Share By Type (2014)
Fig. 49 Japan Traditional Human Insulin Market Share By Type (2014)
Fig. 50 Japan Modern Human Insulin Market Share By Type (2014)
Fig. 51 China Human Insulin Market Share By Type (2014)
Fig. 52 China Traditional Human Insulin Market Share By Type (2014)
Fig. 53 China Modern Human Insulin Market Share By Type (2014)
Fig. 54 India Human Insulin Market Share By Type (2014)
Fig. 55 India Traditional Human Insulin Market Share By Type (2014)
Fig. 56 India Modern Human Insulin Market Share By Type (2014)
Fig. 57 Rest Of The World Human Insulin Market Share By Type (2014)
Fig. 58 Rest Of The World Traditional Human Insulin Market Share By Type (2014)
Fig. 59 Rest Of The World Modern Human Insulin Market Share By Type (2014)
Fig. 60 Porter’S Five Forces Of Competitive Position Analysis
Fig. 61 Competitive Positioning Of Key Competitors

List Of Tables
Table 1 Specific Primary And Secondary Sources Used For This Publication
Table 2 Global Human Insulin Market Snapshot (2015 And 2020)
Table 3 Drivers For The Market: Impact Analysis
Table 4 Restraints For The Market: Impact Analysis
Table 5 Global Human Insulin Market Breakdown By Type, $M (2011-2014)
Table 6 Global Human Insulin Market Breakdown By Type, $M (2015-2020)
Table 7 Global Traditional Human Insulin Market Breakdown By Type, $M (2011-2014)
Table 8 Global Traditional Human Insulin Market Breakdown By Type, $M (2015-2020)
Table 9 Global Modern Human Insulin Market Breakdown By Type, $M (2011-2014)
Table 10 Global Modern Human Insulin Market Breakdown By Type, $M (2015-2020)
Table 11 Global Human Insulin Market Breakdown By Region, $M (2011-2014)
Table 12 Global Human Insulin Market Breakdown By Region, $M (2015-2020)
Table 13 Global Traditional Human Insulin Market Breakdown By Region, $M (2011-2014)
Table 14 Global Traditional Human Insulin Market Breakdown By Region, $M (2015-2020)
Table 15 Global Modern Human Insulin Market Breakdown By Region, $M (2011-2014)
Table 16 Global Modern Human Insulin Market Breakdown By Region, $M (2015-2020)
Table 17 Global Short Acting Human Insulin Market Breakdown By Region, $M (2011-2014)
Table 18 Global Short Acting Human Insulin Market Breakdown By Region, $M (2015-2020)
Table 19 Global Intermediate Acting Human Insulin Market Breakdown By Region, $M (2011-2014)
Table 20 Global Intermediate Acting Human Insulin Market Breakdown By Region, $M (2015-2020)
Table 21 Global Premixed Human Insulin Market Breakdown By Region, $M (2011-2014)
Table 22 Global Premixed Human Insulin Market Breakdown By Region, $M (2015-2020)
Table 23 Global Long Acting Human Insulin Market Breakdown By Region, $M (2011-2014)
Table 24 Global Long Acting Human Insulin Market Breakdown By Region, $M (2015-2020)
Table 25 Global Rapid Acting Human Insulin Market Breakdown By Region, $M (2011-2014)
Table 26 Global Rapid Acting Human Insulin Market Breakdown By Region, $M (2015-2020)
Table 27 Global Premixed Human Insulin Market Breakdown By Region, $M (2011-2014)
Table 28 Global Premixed Human Insulin Market Breakdown By Region, $M (2015-2020)
Table 29 Some Of The Human Insulin Drugs In Pipeline By Various Companies
Table 30 Global Human Insulin Market Breakdown By Brand, $M (2011-2014)
Table 31 Global Human Insulin Market Breakdown By Brand, $M (2015-2020)
Table 32 North America Human Insulin Market Breakdown By Country, $M (2011-2014)
Table 33 North America Human Insulin Market Breakdown By Country, $M (2015-2020)
Table 34 North America Human Insulin Market Breakdown By Type, $M (2011-2014)
Table 35 North America Human Insulin Market Breakdown By Type, $M (2015-2020)
Table 36 North America Traditional Human Insulin Market Breakdown By Type, $M (2011-2014)
Table 37 North America Traditional Human Insulin Market Breakdown By Type, $M (2015-2020)
Table 38 North America Modern Human Insulin Market Breakdown By Type, $M (2011-2014)
Table 39 North America Modern Human Insulin Market Breakdown By Type, $M (2015-2020)
Table 40 The U.S. Human Insulin Market Breakdown By Type, $M (2011-2014)
Table 41 The U.S. Human Insulin Market Breakdown By Type, $M (2015-2020)
Table 42 The U.S. Traditional Human Insulin Market Breakdown By Type, $M (2011-2014)
Table 43 The U.S. Traditional Human Insulin Market Breakdown By Type, $M (2015-2020)
Table 44 The U.S. Modern Human Insulin Market Breakdown By Type, $M (2011-2014)
Table 45 The U.S. Modern Human Insulin Market Breakdown By Type, $M (2015-2020)
Table 46 Canada Human Insulin Market Breakdown By Type, $M (2011-2014)
Table 47 Canada Human Insulin Market Breakdown By Type, $M (2015-2020)
Table 48 Canada Traditional Human Insulin Market Breakdown By Type, $M (2011-2014)
Table 49 Canada Traditional Human Insulin Market Breakdown By Type, $M (2015-2020)
Table 50 Canada Modern Human Insulin Market Breakdown By Type, $M (2011-2014)
Table 51 Canada Modern Human Insulin Market Breakdown By Type, $M (2015-2020)
Table 52 Europe Human Insulin Market Breakdown By Country, $M (2011-2014)
Table 53 Europe Human Insulin Market Breakdown By Country, $M (2015-2020)
Table 54 Europe Human Insulin Market Breakdown By Type, $M (2011-2014)
Table 55 Europe Human Insulin Market Breakdown By Type, $M (2015-2020)
Table 56 Europe Traditional Human Insulin Market Breakdown By Type, $M (2011-2014)
Table 57 Europe Traditional Human Insulin Market Breakdown By Type, $M (2015-2020)
Table 58 Europe Modern Human Insulin Market Breakdown By Type, $M (2011-2014)
Table 59 Europe Modern Human Insulin Market Breakdown By Type, $M (2015-2020)
Table 60 Germany Human Insulin Market Breakdown By Type, $M (2011-2014)
Table 61 Germany Human Insulin Market Breakdown By Type, $M (2015-2020)
Table 62 Germany Traditional Human Insulin Market Breakdown By Type, $M (2011-2014)
Table 63 Germany Traditional Human Insulin Market Breakdown By Type, $M (2015-2020)
Table 64 Germany Modern Human Insulin Market Breakdown By Type, $M (2011-2014)
Table 65 Germany Modern Human Insulin Market Breakdown By Type, $M (2015-2020)
Table 66 The U.K. Human Insulin Market Breakdown By Type, $M (2011-2014)
Table 67 The U.K. Human Insulin Market Breakdown By Type, $M (2015-2020)
Table 68 The U.K. Traditional Human Insulin Market Breakdown By Type, $M (2011-2014)
Table 69 The U.K. Traditional Human Insulin Market Breakdown By Type, $M (2015-2020)
Table 70 The U.K. Modern Human Insulin Market Breakdown By Type, $M (2011-2014)
Table 71 The U.K. Modern Human Insulin Market Breakdown By Type, $M (2015-2020)
Table 72 France Human Insulin Market Breakdown By Type, $M (2011-2014)
Table 73 France Human Insulin Market Breakdown By Type, $M (2015-2020)
Table 74 France Traditional Human Insulin Market Breakdown By Type, $M (2011-2014)
Table 75 France Traditional Human Insulin Market Breakdown By Type, $M (2015-2020)
Table 76 France Modern Human Insulin Market Breakdown By Type, $M (2011-2014)
Table 77 France Modern Human Insulin Market Breakdown By Type, $M (2015-2020)
Table 78 Asia-Pacific Human Insulin Market Breakdown By Country, $M (2011-2014)
Table 79 Asia-Pacific Human Insulin Market Breakdown By Country, $M (2015-2020)
Table 80 Asia-Pacific Human Insulin Market Breakdown By Type, $M (2011-2014)
Table 81 Asia-Pacific Human Insulin Market Breakdown By Type, $M (2015-2020)
Table 82 Asia-Pacific Traditional Human Insulin Market Breakdown By Type, $M (2011-2014)
Table 83 Asia-Pacific Traditional Human Insulin Market Breakdown By Type, $M (2015-2020)
Table 84 Asia-Pacific Modern Human Insulin Market Breakdown By Type, $M (2011-2014)
Table 85 Asia-Pacific Modern Human Insulin Market Breakdown By Type, $M (2015-2020)
Table 86 Japan Human Insulin Market Breakdown By Type, $M (2011-2014)
Table 87 Japan Human Insulin Market Breakdown By Type, $M (2015-2020)
Table 88 Japan Traditional Human Insulin Market Breakdown By Type, $M (2011-2014)
Table 89 Japan Traditional Human Insulin Market Breakdown By Type, $M (2015-2020)
Table 90 Japan Modern Human Insulin Market Breakdown By Type, $M (2011-2014)
Table 91 Japan Modern Human Insulin Market Breakdown By Type, $M (2015-2020)
Table 92 China Human Insulin Market Breakdown By Type, $M (2011-2014)
Table 93 China Human Insulin Market Breakdown By Type, $M (2015-2020)
Table 94 China Traditional Human Insulin Market Breakdown By Type, $M (2011-2014)
Table 95 China Traditional Human Insulin Market Breakdown By Type, $M (2015-2020)
Table 96 China Modern Human Insulin Market Breakdown By Type, $M (2011-2014)
Table 97 China Modern Human Insulin Market Breakdown By Type, $M (2015-2020)
Table 98 India Human Insulin Market Breakdown By Type, $M (2011-2014)
Table 99 India Human Insulin Market Breakdown By Type, $M (2015-2020)
Table 100 India Traditional Human Insulin Market Breakdown By Type, $M (2011-2014)
Table 101 India Traditional Human Insulin Market Breakdown By Type, $M (2015-2020)
Table 102 India Modern Human Insulin Market Breakdown By Type, $M (2011-2014)
Table 103 India Modern Human Insulin Market Breakdown By Type, $M (2015-2020)
Table 104 Rest Of The World Human Insulin Market Breakdown By Type, $M (2011-2014)
Table 105 Rest Of The World Human Insulin Market Breakdown By Type, $M (2015-2020)
Table 106 Rest Of The World Traditional Human Insulin Market Breakdown By Type, $M (2011-2014)
Table 107 Rest Of The World Traditional Human Insulin Market Breakdown By Type, $M (2015-2020)
Table 108 Rest Of The World Modern Human Insulin Market Breakdown By Type, $M (2011-2014)
Table 109 Rest Of The World Modern Human Insulin Market Breakdown By Type, $M (2015-2020)
Table 110 Biocon Ltd.- Key Facts
Table 111 Tonghuadongbao Pharmaceuticals Co., Ltd.-Key Facts
Table 112 Adocia-Key Facts
Table 113 Merck & Co.-Key Facts
Table 114 Julphar-Key Facts
Table 115 Pfizer, Inc.- Key Facts
Table 116 Bristol-Myers Squibb Company-Key Facts
Table 117 Glaxosmithkline Plc-Key Facts
Table 118 Oramed Pharmaceuticals, Inc.-Key Facts
Table 119 Novo Nordisk A/S-Key Facts
Table 120 Eli Lilly And Company-Key Facts
Table 121 Sanofi-Key Facts
Note: Product cover images may vary from those shown
3 of 5

Loading
LOADING...

4 of 5

FEATURED COMPANIES

  • ADOCIA
  • Biocon Ltd.
  • Eli Lilly and Company
  • GlaxoSmithKline Plc
  • Julphar
  • Merck & Co.
  • MORE
The research offers Human Insulin market size and market forecast for the period 2011 to 2020. The market size is breakdown as follows:

Global Market Breakdown:

- By type - includes global market size of traditional human insulin and modern human insulin
- By brand - includes global market size of Lantus, Novorapid, Humalog, Novomix, Levemir, Apidar, Humulin and Insuman
- By region - includes market size of North America, Europe, Asia-Pacific and Rest of World

Global Market Breakdown by Type:

- Traditional human insulin market breakdown by region - North America, Europe, Asia-Pacific and Rest of World
- Modern human insulin breakdown by region - North America, Europe, Asia-Pacific and Rest of World

Global Market Breakdown by Type of Traditional Human Insulin:

- Short acting human insulin market breakdown by region - North America, Europe, Asia-Pacific and Rest of World
- Intermediate acting human insulin market breakdown by region - North America, Europe, Asia-Pacific and Rest of World
- Premixed human insulin market breakdown by region - North America, Europe, Asia-Pacific and Rest of World

Global Market Breakdown by Type of Modern Human Insulin:

- Long acting human insulin market breakdown by region - North America, Europe, Asia-Pacific and Rest of World
- Rapid acting human insulin market breakdown by region - North America, Europe, Asia-Pacific and Rest of World
- Premixed human insulin market breakdown by region - North America, Europe, Asia-Pacific and Rest of World

Global Market Breakdown by Geography:

North America Market Breakdown

- North America market breakdown by type:
- - Traditional human insulin by type - short acting human insulin, intermediate acting human insulin and premixed human insulin
- - Modern human insulin by type - long action human insulin, rapid acting human insulin and premixed human insulin
- North America market breakdown by country - the U.S., Canada and Rest of North America
- - The U.S. market breakdown by type -
- - - Traditional human insulin - short acting human insulin, intermediate acting human insulin and premixed human insulin
- - - Modern human insulin - long action human insulin, rapid acting human insulin and premixed human insulin
- - Canada market breakdown by type -
- - - Traditional human insulin - short acting human insulin, intermediate acting human insulin and premixed human insulin
- - - Modern human insulin - long action human insulin, rapid acting human insulin and premixed human insulin

Europe Market Breakdown

- Europe market breakdown by type:
- - Traditional human insulin by type - short acting human insulin, intermediate acting human insulin and premixed human insulin
- - Modern human insulin by type - long action human insulin, rapid acting human insulin and premixed human insulin
- Europe market breakdown by country - Germany, France, the U.K. and Rest of Europe
- - Germany market breakdown by type -
- - - Traditional human insulin - short acting human insulin, intermediate acting human insulin and premixed human insulin
- - - Modern human insulin - long action human insulin, rapid acting human insulin and premixed human insulin
- - France market breakdown by type -
- - - Traditional human insulin - short acting human insulin, intermediate acting human insulin and premixed human insulin
- - - Modern human insulin - long action human insulin, rapid acting human insulin and premixed human insulin
- - The U.K. market breakdown by type -
- - - Traditional human insulin - short acting human insulin, intermediate acting human insulin and premixed human insulin
- - - Modern human insulin - long action human insulin, rapid acting human insulin and premixed human insulin

Asia-Pacific Market Breakdown

- Asia-Pacific market breakdown by type:
- - Traditional human insulin by type - short acting human insulin, intermediate acting human insulin and premixed human insulin
- - Modern human insulin by type - long action human insulin, rapid acting human insulin and premixed human insulin
- Asia-Pacific market breakdown by country - Japan, India, China and Rest of Asia-Pacific
- - Japan market breakdown by type -
- - - Traditional human insulin - short acting human insulin, intermediate acting human insulin and premixed human insulin
- - - Modern human insulin - long action human insulin, rapid acting human insulin and premixed human insulin
- - India market breakdown by type -
- - - Traditional human insulin - short acting human insulin, intermediate acting human insulin and premixed human insulin
- - - Modern human insulin - long action human insulin, rapid acting human insulin and premixed human insulin
- - China market breakdown by type -
- - - Traditional human insulin - short acting human insulin, intermediate acting human insulin and premixed human insulin
- - - Modern human insulin - long action human insulin, rapid acting human insulin and premixed human insulin

Rest Of World Market Breakdown

- Rest of World market breakdown by type:
- - Traditional human insulin by type - short acting human insulin, intermediate acting human insulin and premixed human insulin
- - Modern human insulin by type - long action human insulin, rapid acting human insulin and premixed human insulin
Note: Product cover images may vary from those shown
5 of 5
- ADOCIA
- Biocon Ltd.
- Bristol-Myers Squibb Company
- Eli Lilly and Company
- GlaxoSmithKline Plc
- Julphar
- Merck & Co.
- Novo Nordisk A/S
- Oramed Pharmaceuticals, Inc.
- Pfizer, Inc.
- Sanofi
- TonghuaDongbao Pharmaceuticals Co., Ltd
Note: Product cover images may vary from those shown
6 of 5
Note: Product cover images may vary from those shown
Order Online - visit: https://www.researchandmarkets.com/reports/3359689
Adroll
adroll